Two Sigma Investments LP Acquires 109,522 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Two Sigma Investments LP lifted its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 114.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 204,817 shares of the company's stock after purchasing an additional 109,522 shares during the quarter. Two Sigma Investments LP owned about 0.08% of Ryan Specialty worth $13,141,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of RYAN. Barclays PLC grew its holdings in Ryan Specialty by 1.1% in the third quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after purchasing an additional 17,267 shares during the period. SG Americas Securities LLC grew its holdings in Ryan Specialty by 94.2% in the fourth quarter. SG Americas Securities LLC now owns 3,253 shares of the company's stock valued at $209,000 after purchasing an additional 1,578 shares during the period. Janney Montgomery Scott LLC grew its holdings in Ryan Specialty by 4.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 17,825 shares of the company's stock valued at $1,144,000 after purchasing an additional 831 shares during the period. Avior Wealth Management LLC boosted its stake in shares of Ryan Specialty by 2,113.3% in the fourth quarter. Avior Wealth Management LLC now owns 3,497 shares of the company's stock worth $224,000 after acquiring an additional 3,339 shares during the last quarter. Finally, Exchange Traded Concepts LLC boosted its stake in shares of Ryan Specialty by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company's stock worth $755,000 after acquiring an additional 295 shares during the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 52.21% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

RYAN has been the topic of a number of research analyst reports. UBS Group lifted their price target on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Morgan Stanley lifted their price objective on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. Wells Fargo & Company reduced their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Barclays reduced their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Finally, The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $74.00 to $81.00 in a research report on Tuesday, May 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $75.58.

Ryan Specialty Stock Down 0.1%

Ryan Specialty stock traded down $0.09 during midday trading on Thursday, hitting $69.13. The stock had a trading volume of 91,868 shares, compared to its average volume of 982,544. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market cap of $18.14 billion, a P/E ratio of 100.20, a P/E/G ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 12 month low of $52.34 and a 12 month high of $77.16. The business has a fifty day moving average price of $69.97 and a 200 day moving average price of $68.76.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting analysts' consensus estimates of $0.39. The company had revenue of $690.17 million during the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Ryan Specialty's quarterly revenue was up 25.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.35 earnings per share. Research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were issued a dividend of $0.12 per share. The ex-dividend date was Tuesday, May 13th. This represents a $0.48 annualized dividend and a yield of 0.69%. Ryan Specialty's payout ratio is 141.18%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.